阜外医院徐波等研究被ESC血运重建指南引用:左主干介入术者每年应至少进行25例手术,为IIa类推荐

2018-08-31 文韬 中国循环杂志

在今年ESC年会上公布的新版《心肌血运重建指南》中,阜外医院徐波教授等的“术者经验及手术量与左主干介入治疗预后有关”文章被引用。

在今年ESC年会上公布的新版《心肌血运重建指南》中,阜外医院徐波教授等的“术者经验及手术量与左主干介入治疗预后有关”文章被引用。

发表在JACC介入子刊的这项研究表明,对于左主干病变的患者而言,由手术经验丰富的医生做介入治疗,30天和3年时的效果明显较好。

研究共入选了1948例行左主干病变行介入治疗的患者。术者经验丰富被定义为每年行左主干介入治疗的例数至少达15例,平均每年25例,经验相对较少的术者每年行左主干介入治疗仅平均4例。

研究发现,与手术量较少的术者相比,经验丰富术者所治疗的患者术后30天心脏死亡率更低。术后3年校正后心脏死亡风险降低了51%(HR=0.49,P=0.009)。

上述结果提示,要想优化左主干介入治疗等风险较高的复杂手术效果,需要术者具备一定的经验。

根据这一研究,ESC新版《心肌血运重建指南》建议,左主干介入术者每年应至少进行25例左主干介入手术,推荐级别为IIa。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1816081, encodeId=cd061816081c5, content=<a href='/topic/show?id=fc4e9e348b6' target=_blank style='color:#2F92EE;'>#阜外医#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97348, encryptionId=fc4e9e348b6, topicName=阜外医)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c97a2500111, createdName=thinkibmz_44722594, createdTime=Sat Apr 20 12:34:00 CST 2019, time=2019-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1718535, encodeId=357e1e1853506, content=<a href='/topic/show?id=35534e966a0' target=_blank style='color:#2F92EE;'>#左主干#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47966, encryptionId=35534e966a0, topicName=左主干)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5fa32580320, createdName=cathymary, createdTime=Sun Dec 16 23:34:00 CST 2018, time=2018-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1293677, encodeId=efc912936e71a, content=<a href='/topic/show?id=4c6e9e34931' target=_blank style='color:#2F92EE;'>#阜外医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97349, encryptionId=4c6e9e34931, topicName=阜外医院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8942242, createdName=jj000001, createdTime=Sun Sep 02 04:34:00 CST 2018, time=2018-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=341981, encodeId=53b034198157, content=学习了,谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Fri Aug 31 13:43:48 CST 2018, time=2018-08-31, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1816081, encodeId=cd061816081c5, content=<a href='/topic/show?id=fc4e9e348b6' target=_blank style='color:#2F92EE;'>#阜外医#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97348, encryptionId=fc4e9e348b6, topicName=阜外医)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c97a2500111, createdName=thinkibmz_44722594, createdTime=Sat Apr 20 12:34:00 CST 2019, time=2019-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1718535, encodeId=357e1e1853506, content=<a href='/topic/show?id=35534e966a0' target=_blank style='color:#2F92EE;'>#左主干#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47966, encryptionId=35534e966a0, topicName=左主干)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5fa32580320, createdName=cathymary, createdTime=Sun Dec 16 23:34:00 CST 2018, time=2018-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1293677, encodeId=efc912936e71a, content=<a href='/topic/show?id=4c6e9e34931' target=_blank style='color:#2F92EE;'>#阜外医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97349, encryptionId=4c6e9e34931, topicName=阜外医院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8942242, createdName=jj000001, createdTime=Sun Sep 02 04:34:00 CST 2018, time=2018-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=341981, encodeId=53b034198157, content=学习了,谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Fri Aug 31 13:43:48 CST 2018, time=2018-08-31, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1816081, encodeId=cd061816081c5, content=<a href='/topic/show?id=fc4e9e348b6' target=_blank style='color:#2F92EE;'>#阜外医#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97348, encryptionId=fc4e9e348b6, topicName=阜外医)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c97a2500111, createdName=thinkibmz_44722594, createdTime=Sat Apr 20 12:34:00 CST 2019, time=2019-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1718535, encodeId=357e1e1853506, content=<a href='/topic/show?id=35534e966a0' target=_blank style='color:#2F92EE;'>#左主干#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47966, encryptionId=35534e966a0, topicName=左主干)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5fa32580320, createdName=cathymary, createdTime=Sun Dec 16 23:34:00 CST 2018, time=2018-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1293677, encodeId=efc912936e71a, content=<a href='/topic/show?id=4c6e9e34931' target=_blank style='color:#2F92EE;'>#阜外医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97349, encryptionId=4c6e9e34931, topicName=阜外医院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8942242, createdName=jj000001, createdTime=Sun Sep 02 04:34:00 CST 2018, time=2018-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=341981, encodeId=53b034198157, content=学习了,谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Fri Aug 31 13:43:48 CST 2018, time=2018-08-31, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1816081, encodeId=cd061816081c5, content=<a href='/topic/show?id=fc4e9e348b6' target=_blank style='color:#2F92EE;'>#阜外医#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97348, encryptionId=fc4e9e348b6, topicName=阜外医)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c97a2500111, createdName=thinkibmz_44722594, createdTime=Sat Apr 20 12:34:00 CST 2019, time=2019-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1718535, encodeId=357e1e1853506, content=<a href='/topic/show?id=35534e966a0' target=_blank style='color:#2F92EE;'>#左主干#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47966, encryptionId=35534e966a0, topicName=左主干)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5fa32580320, createdName=cathymary, createdTime=Sun Dec 16 23:34:00 CST 2018, time=2018-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1293677, encodeId=efc912936e71a, content=<a href='/topic/show?id=4c6e9e34931' target=_blank style='color:#2F92EE;'>#阜外医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97349, encryptionId=4c6e9e34931, topicName=阜外医院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8942242, createdName=jj000001, createdTime=Sun Sep 02 04:34:00 CST 2018, time=2018-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=341981, encodeId=53b034198157, content=学习了,谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Fri Aug 31 13:43:48 CST 2018, time=2018-08-31, status=1, ipAttribution=)]
    2018-08-31 惠映实验室

    学习了,谢谢分享。

    0

相关资讯

每日ESC:非布索坦对高尿酸血症患者的心脑血管和肾脏的保护作用

在本届ESC大会上,FREED研究(Febuxostat for Cerebral and caRdiorenovascular Events prEvEntion stuDy,NCT01984749)的最新研究结果已由日本熊本大学的Sunao Kojima教授公布,详细介绍了痛风药物非布索坦(Febuxostat)对心血脑管和肾脏的保护作用。

ESC 重磅:陈韵岱教授:2018 ESC 心肌血运重建指南抗栓治疗更新要点解读!

2018年8月25日至29日,欧洲心脏病学会(ESC)年会于德国慕尼黑盛大召开,本次大会的主题是心脏瓣膜病。当地时间2018年8月26日上午,ESC联合欧洲心胸外科协会(EACTS)发布《2018年心肌血运重建治疗指南》。

ESC 重磅:钱菊英教授:妊娠期CVD指南将帮助中国医师解决哪些实际问题?

我们特邀了复旦大学附属中山医院心内科副主任、内科教研室副主任钱菊英教授对妊娠期心血管疾病指南作了简要解读。

ESC 重磅:颜红兵教授:GLOBAL LEADERS研究,意料之中的结果,改变时代的研究!

2018年8月25日至29日,欧洲心脏病学会(ESC)年会于德国慕尼黑盛大召开。当地时间2018年8月27日上午,GLOBAL LEADERS研究结果重磅公布,中国医学科学院阜外医院颜红兵教授为我们作出详细解读。

每日ESC:睡眠时间不超过5小时,心血管疾病发病将面临双倍风险

德国慕尼黑时间2018年8月26日,ESC发布了一项与日常生活息息相关的研究——每晚睡眠时间不超过5小时的中年男性发生重大心血管事件的风险是每天睡7-8小时男性的两倍。

ESC2018:阿司匹林用于糖尿病患者心血管疾病一级预防再添新证

8月25日~29日,2018欧洲心脏病学会年会(ESC2018)在德国慕尼黑举行。当地时间26日下午,ASCEND研究结果正式发布,为阿司匹林用于糖尿病患者心血管疾病一级预防再添新证。既往研究表明,对于不同危险分层的患者,阿司匹林的一级预防作用存在差异。ASCEND研究提示,糖尿病患者采用阿司匹林一级预防策略显著降低严重血管事件的风险,但同时出血风险也增加。那么,阿司匹林在糖尿病患者ASCVD一级